Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Drug Discovery Today
|
February 13, 2002
The utility of predictivity in drug discovery and use
Norton P Peet
Drug Discovery Today
|
September 27, 2005
Biotechnology in India
Norton P Peet
Drug Discovery Today
|
May 4, 2010
Drug resistance: a growing problem
Norton P Peet
Drug Discovery Today
|
February 13, 2004
The multiple orthogonal tools approach to define molecular causation in the validation of druggable targets
Larry W Hardy, Norton P Peet
Molecular Cancer Therapeutics
|
June 26, 2021
Current Development of Glioblastoma Therapeutic Agents
Zilai Wang, Norton P Peet, Pin Zhang, et al.
Synthetic Communications
|
January 5, 2010
A Survey of Solvents for the Conrad-Limpach Synthesis of 4-Hydroxyquinolones
Jean-Cristophe Brouet, Shen Gu, Norton P Peet, et al.
Tetrahedron Letters
|
April 4, 2015
Diels-Alder reactions of five-membered heterocycles containing one heteroatom
Xiaoyuan Ding, Son T Nguyen, John D Williams, et al.
Drug Discovery Today
|
July 26, 2011
The challenge of developing robust drugs to overcome resistance
Amy C Anderson, Michael P Pollastri, Celia A Schiffer, et al.
Synthetic Communications
|
November 20, 2013
Syntheses of Benzo[<i>b</i>]furan-6-carbonitrile and 6-Cyanobenzo[<i>b</i>]furan-2-boronic Acid Pinacol Ester
John D Williams, Xiaoyuan Ding, Son Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 1, 2010
A concise, total synthesis and antibacterial evaluation of 2-hydroxy-1-(1H-indol-3-yl)-4-methylpentan-3-one
Son T Nguyen, Michelle M Butler, Laszlo Varady, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Drug Discovery Today
|
February 13, 2002
The utility of predictivity in drug discovery and use
Norton P Peet
Drug Discovery Today
|
September 27, 2005
Biotechnology in India
Norton P Peet
Drug Discovery Today
|
May 4, 2010
Drug resistance: a growing problem
Norton P Peet
Drug Discovery Today
|
February 13, 2004
The multiple orthogonal tools approach to define molecular causation in the validation of druggable targets
Larry W Hardy, Norton P Peet
Molecular Cancer Therapeutics
|
June 26, 2021
Current Development of Glioblastoma Therapeutic Agents
Zilai Wang, Norton P Peet, Pin Zhang, et al.
Synthetic Communications
|
January 5, 2010
A Survey of Solvents for the Conrad-Limpach Synthesis of 4-Hydroxyquinolones
Jean-Cristophe Brouet, Shen Gu, Norton P Peet, et al.
Tetrahedron Letters
|
April 4, 2015
Diels-Alder reactions of five-membered heterocycles containing one heteroatom
Xiaoyuan Ding, Son T Nguyen, John D Williams, et al.
Drug Discovery Today
|
July 26, 2011
The challenge of developing robust drugs to overcome resistance
Amy C Anderson, Michael P Pollastri, Celia A Schiffer, et al.
Synthetic Communications
|
November 20, 2013
Syntheses of Benzo[<i>b</i>]furan-6-carbonitrile and 6-Cyanobenzo[<i>b</i>]furan-2-boronic Acid Pinacol Ester
John D Williams, Xiaoyuan Ding, Son Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 1, 2010
A concise, total synthesis and antibacterial evaluation of 2-hydroxy-1-(1H-indol-3-yl)-4-methylpentan-3-one
Son T Nguyen, Michelle M Butler, Laszlo Varady, et al.
Page
of 6